|
2024
|
Invention
|
Heterocyclic compounds of formula (i) for use in the treatment of spinal muscular atrophy via mod... |
|
|
Invention
|
Compounds for treating spinal muscular atrophy and huntington's disease. The present disclosure p... |
|
|
Invention
|
Tyk2 inhibitors. This disclosure relates to compounds of formula (I), or pharmaceutically accepta... |
|
|
Invention
|
Redirection of aav capsids for central nervous system targeting. The present disclosure pertains ... |
|
|
Invention
|
Methods for identifying aav capsid variants with desired characteristics. The present disclosure ... |
|
|
Invention
|
Anti-transferrin receptor antibodies and uses thereof cross reference to related applications. Th... |
|
|
Invention
|
Methods for evaluating patients.
Methods for evaluating subjects having conditions associated wi... |
|
|
Invention
|
Methods for treating alzheimer's disease. A method for treatment of a human subject for Alzheimer... |
|
|
Invention
|
Emopamil-binding protein inhibitors and uses thereof. Provided are compounds of Formula (I), or p... |
|
|
Invention
|
Emopamil-binding protein inhibitors and uses thereof. Provided are compounds of the Formula (I): ... |
|
|
Invention
|
Pyrimidinyl tyrosine kinase inhibitors.
The present invention provides compounds and composition... |
|
|
Invention
|
Method of assessing risk of pml.
The invention relates to methods of assessing a patient's risk ... |
|
|
Invention
|
Indole and pyrroloypyridine derivatives as gpr17 modulators. Disclosed is a compound represented ... |
|
|
Invention
|
Medical device having non-filtered csf withdrawal pathway.
An implantable medical device for del... |
|
|
Invention
|
Hydrophobic interaction chromatography for purification of oligonucleotides.
The present inventi... |
|
|
Invention
|
Glycogen synthase kinase 3 inhibitors and uses thereof. The present disclosure provides compounds... |
|
|
Invention
|
Method of assessing risk of pml.
The invention relates to methods of assessing a patient' s risk... |
|
|
Invention
|
O-glycoprotein-2-acetamido-2-deoxy-3-d-glucopyranosidase inhibitors. Described herein are compoun... |
|
|
Invention
|
Methods of treating or preventing spinal muscular atrophy.
Featured are methods for the treatmen... |
|
|
Invention
|
Compounds and methods for reducing tau expression.
Provided are compounds, methods, and pharmace... |
|
|
Invention
|
Combination of a btk inhibitor and a fumaric acid ester for use in the treatment of multiple scle... |
|
|
Invention
|
Btk inhibitor for treating multiple sclerosis. The present disclosure provides methods of treatin... |
|
|
Invention
|
Immunosuppressive regimens and methods thereof. Among other things, the present disclosure provid... |
|
|
Invention
|
1h-pyrrolo[2,3-b]pyridin-4-yl]-2-oxopyrrolidine-3-carbonitrile derivatives as tyrosine kinase 2 (... |
|
|
Invention
|
Methods of recombinant adeno-associated virus (raav) production. Aspects of the present disclosur... |
|
|
Invention
|
Engineered cells and cell lines for aav production and methods of making and using the same. The ... |
|
|
Invention
|
Packaging plasmids for aav production. The present disclosure provides improved packaging plasmid... |
|
|
Invention
|
Anti-transferrin receptor antibodies and uses thereof. The present disclosure provides anti-trans... |
|
|
Invention
|
Rgd-containing peptides for delivering payloads. The present disclosure pertains to muscle-target... |
|
|
G/S
|
Pharmaceutical preparations for the treatment of eye diseases, disorders, and conditions; ophthal... |
|
|
G/S
|
Pharmaceutical preparations for use in the treatment of psychiatric diseases and disorders, namel... |
|
|
Invention
|
Methods and products for evaluating an immune response to a therapeutic protein.
The invention r... |
|
2023
|
Invention
|
Methods of treating inflammatory and autoimmune diseases.
Natalizumab is a safe and efficacious ... |
|
|
Invention
|
Nrf2 activator.
Provided are compounds of Formula I, or pharmaceutically acceptable salts thereo... |
|
|
G/S
|
Pharmaceutical preparations; pharmaceutical preparations for use in the treatment of psychiatric ... |
|
|
G/S
|
Pharmaceutical preparations; pharmaceutical preparations for
use in the treatment of psychiatric... |
|
|
Invention
|
Emopamil-binding protein inhibitors and uses thereof.
Provided are compounds of the Formula (I):... |
|
|
Invention
|
Emopamil-binding protein inhibitors and uses thereof.
Provided are compounds of the Formula (I) ... |
|
|
G/S
|
Computer software for neuro-psychology tests; computer software for use to detect neurological di... |
|
2022
|
Invention
|
Modified actrii proteins and methods of use thereof.
An isolated protein comprising a mutant sol... |
|
|
Invention
|
Methods and systems for transfecting host cells.
The present disclosure pertains to methods for ... |
|
|
Invention
|
Formulations comprising fab-peg.
The present invention relates to the field of pharmaceutical co... |
|
|
Invention
|
Method for detecting a lipidated protein via fluorescence resonance energy transfer (fret).
Aspe... |
|
|
Invention
|
Btk inhibitors.
Provided are compounds of Formula (I) or pharmaceutically acceptable salts there... |
|
|
Invention
|
Btk inhibitors.
Provided are compounds of Formula (I): or pharmaceutically acceptable salts ther... |
|
|
Invention
|
Methods for treating alzheimer's disease.
Provided are methods for treating Alzheimer's disease ... |
|
|
Invention
|
Diroximel fumarate particles having improved flow properties and methods of making same.
Many ac... |
|
|
G/S
|
Medical apparatus and instruments, namely, auto injection devices for pharmaceuticals |
|
|
Invention
|
Compounds for targeting degradation of irak4 proteins.
This disclosure relates to compounds of F... |
|
|
Invention
|
Synthetic preparation for diroximel fumarate.
Disclosed is a method of preparing diroximel fumar... |
|
|
Invention
|
Compounds for targeting degradation of bruton's tyrosine kinase.
This disclosure relates to comp... |
|
|
G/S
|
Medical diagnostic reagents and assays for testing of body fluids |
|
|
Invention
|
Tyk2 inhibitors.
This disclosure relates to compounds of formula (I′), or pharmaceutically accep... |
|
2021
|
G/S
|
Providing medical and health information in the field of neurology and neurologic disorders. |
|
|
G/S
|
Pharmaceutical preparations for the treatment of amyotrophic lateral sclerosis and other neurolog... |
|
|
G/S
|
Pharmaceutical preparations for the treatment of amyotrophic lateral sclerosis |
|
|
G/S
|
Providing medical and health information in the field of neurology and neurologic disorders |
|
|
G/S
|
Pharmaceutical preparations for the treatment of
neurological disorders; pharmaceutical preparat... |
|
|
G/S
|
Pharmaceutical preparations for the treatment of neurological disorders; pharmaceutical preparati... |
|
|
G/S
|
Providing educational information, webcasts, and training materials in the fields of health, medi... |
|
2020
|
G/S
|
Pharmaceutical preparations for the treatment of neurologic disorders Providing medical and healt... |
|
|
G/S
|
Pharmaceutical preparations for the treatment of neurologic disorders; Pharmaceutical preparation... |
|
|
G/S
|
Pharmaceutical preparations for the treatment of neurological and neurodegenerative diseases. |
|
|
G/S
|
Pharmaceutical preparations for the treatment of choroidal diseases and disorders; pharmaceutical... |
|
|
G/S
|
Providing webcasts in the fields of health, medical conditions, and treatments; development and d... |
|
|
G/S
|
Pharmaceutical preparations for the treatment of amyotrophic lateral sclerosis. |
|
|
G/S
|
Pharmaceutical preparations for the treatment of amyotrophic
lateral sclerosis and other neurolo... |
|
|
G/S
|
Pharmaceutical preparations for the treatment of neurological disorders, namely, Alzheimer's Dise... |
|
|
G/S
|
Providing medical information in the field of neuromuscular diseases. |
|
|
G/S
|
Providing health information in the field of inflammatory disorders, namely, providing patient su... |
|
|
G/S
|
Pharmaceutical preparations. |
|
|
G/S
|
Pharmaceutical preparations for the treatment of liver diseases and disorders; pharmaceutical pre... |
|
|
G/S
|
Providing medical information in the field of neuromuscular diseases |
|
|
G/S
|
Providing news and information in the field of medicine. |
|
|
G/S
|
Educational services related to the medical field; medical educational program in the field of ne... |
|
2019
|
G/S
|
Providing of information relating to healthcare via the internet for educational purposes; educat... |
|
|
G/S
|
Computer software and downloadable applications for mobile phones and handheld computers for test... |
